Home page > Publications
Publications
We present here key papers published in medical literature, to gain deeper understanding in our actions as well as papers that results from the work of MGHI
MGHI papers
- Challenges and opportunities for cancer clinical trials in low- and middle-income countries
- Pilot study of a pediatric metronomic 4-drug regimen
- A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens.
- Access to new drugs in paediatric oncology: can we learn from the ongoing ONC201 saga?
- Accidental Poisoning With 6-MP in a Sibling of Pediatric Patient Treated With Metronomic Maintenance Chemotherapy.
- Beta-blockers disrupt mitochondrial bioenergetics & increase radiotherapy efficacy independently of BAR in medulloblastoma
- Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab–irinotecan in children with low-grade glioma?
- Can Targeted Therapy be Successful without Metronomic Scheduling ?
- Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells
- Covid19: breaking bad news with social distancing in pediatric oncology
- Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-Based Metronomic Chemotherapy: A Bench to Bedside Study
- Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma
- Has the time come for metronomics in low-income and middle-income countries?
- Herbal Medicine Offers Great Potential in Support of Metronomic Cancer Therapy
- Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology
- Investment in cancer studies in countries of low and middle income
- Irinotecan dose schedule for the treatment of Ewing sarcoma—protracted/metronomic schedule—wording
- Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting
- Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect
- METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors
- Metronomic chemotherapy for children in low- and middle-income countries: survey of current practice and opinion of pediatric oncologists," has been accepted for publication in Journal of Global Oncology
- Metronomic Chemotherapy in Pediatric Oncology: A Way Forward for Low-Income Countries?
- Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience
- Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?
- metronomic maintenance for locoregionally advanced nasopharyngeal carcinoma
- Metronomic Maintenance Therapy for Rhabdomyosarcoma
- Metronomic Maintenance With Weekly Vinblastine After Induction With Bevacizumab-Irinotecan in Children With Low-grade Glioma Prevents Early Relapse
- Metronomic metformin and propranolol combination prevents cancer progression and metastasis in breast cancer
- Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
- Metronomic Scheduling of Anticancer Agents for a Refractory Orbital Pseudotumor in a Child
- Metronomic Scheduling of Anticancer Treatment The Next Generation Of Multitarget Therapy?
- Metronomics : India showing the way !
- Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch ?
- Metronomics chemotherapy: time for computational decision support.
- Metronomics during palliative care in paediatric oncology? For sure! But handle me with care
- Metronomics maintenance for HGNET-BCOR tumors of the cerebellum
- Metronomics — fulfilling unmet needs beyond level A evidence
- Metronomics: intrinsic anakoinosis modulator ?
- Metronomics: towards personalized chemotherapy?
- Modeling the Impact of Anticancer Agents on Metastatic Spreading
- Moving forward with metronomic scheduling of anti-cancer treatment: Meeting report of the 2nd international workshop on metronomic and antiangiogenic chemotherapy in paediatric oncology
- Next generation metronomic chemotherapy—report from the Fifth Biennial International Metronomic Meeting May 2016, Mumbai
- Paediatric metronomic four-drug metronomic regimen has anti-tumour activity in pediatric low-grade glioma; the results of a phase II clinical trial.
- Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
- PK/PD-based mathematical modeling identifies an optimal protocol for metronomic chemotherapy
- Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.
- Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
- Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide
- Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-Like Protocol
- Revisiting metronomic vinorelbine with mathematical modelling:
- SFCE-METRO01 four-drug metronomic regimen phase II trial for pediatric extracranial tumor
- Successfully targeting the cancer system with metronomics for medulloblastoma
- Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory ATRT
- Synthesis of novel isoflavene-propranolol hybrids as anti-tumor agents
- Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma
- β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.
- ‘Hard’ Drug Repurposing for Precision Oncology: the Missing Link?
